| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1879* | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 452* | 2021 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 236 | 2022 |
| Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer … S Toback, E Galiza, C Cosgrove, J Galloway, AL Goodman, PA Swift, ... The Lancet Respiratory Medicine 10 (2), 167-179, 2022 | 138 | 2022 |
| British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease D Smith, IA Du Rand, C Addy, T Collyns, S Hart, P Mitchelmore, ... BMJ open respiratory research 7 (1), e000489, 2020 | 71 | 2020 |
| Novel point-of-care biomarker combination tests to differentiate acute bacterial from viral respiratory tract infections to guide antibiotic prescribing: a systematic review HC Carlton, J Savović, S Dawson, PJ Mitchelmore, MMC Elwenspoek Clinical Microbiology and Infection 27 (8), 1096-1108, 2021 | 22 | 2021 |
| Molecular epidemiology of Pseudomonas aeruginosa in an unsegregated bronchiectasis cohort sharing hospital facilities with a cystic fibrosis cohort PJ Mitchelmore, J Randall, MJ Bull, KA Moore, PA O’Neill, K Paszkiewicz, ... Thorax 73 (7), 677-679, 2018 | 19 | 2018 |
| Risk of bacterial transmission in bronchiectasis outpatient clinics P Mitchelmore, C Wilson, D Hettle Current Pulmonology Reports 7, 72-78, 2018 | 10 | 2018 |
| Culture-independent multilocus sequence typing of Pseudomonas aeruginosa for cross-infection screening PJ Mitchelmore, NJ Withers, CD Sheldon, CJ Scotton, AR Brown Diagnostic Microbiology and Infectious Disease 100 (1), 115315, 2021 | 4 | 2021 |
| S113 An epidemiological review of strains of Pseudomonas aeruginosa in a non-cystic fibrosis bronchiectasis cohort P Mitchelmore, A Brown, C Sheldon, C Scotton, M Bull, ... Thorax 70 (Suppl 3), A65-A65, 2015 | 2 | 2015 |
| The Benefits Of An Integrated Vocal Cord Dysfunction Service In Treating A Subgroup Of Patients With Difficult To Control Asthma H Bakere, C McAleer, P Mitchelmore, M Hilton, D Halpin, G Hynes Am J Respir Crit Care Med, A3813-A3813, 2015 | 2* | 2015 |
| Phage Therapy Administration Route, Regimen, and Need for Supplementary Antibiotics in Patients with Chronic Suppurative Lung Disease J Williams, J Severin, B Temperton, PJ Mitchelmore PHAGE 4 (1), 4-10, 2023 | 1 | 2023 |
| Immunodeficiency associated bronchiectasis in the European Bronchiectasis Registry (EMBARC) P Mitchelmore, E Polverino, J Rademacher, C Haworth, A De Soyza, ... European Respiratory Journal 56 (suppl 64), 2020 | 1 | 2020 |
| Culture-independent Multilocus Sequence Typing (MLST) screening for Haemophilus influenzae cross-infection in non-cystic fibrosis bronchiectasis (NCFB) C Wilson, P Mitchelmore, A Brown Access Microbiology 2 (2), 179, 2020 | 1 | 2020 |
| P206 Attitudes towards treating latent tuberculosis in healthcare workers C Wilson, P Mitchelmore, H Dunning, T Burden Thorax 74 (Suppl 2), A201, 2019 | 1 | 2019 |
| P72 Outcomes and patient satisfaction from an established virtual pulmonary nodule clinic P Mitchelmore, K Prior, S Martin, R Hughes, M Dawson, S Jones, ... Thorax 73 (Suppl 4), A140-A141, 2018 | 1 | 2018 |
| Assessment of Pseudomonas aeruginosa epidemiology and the wider microbial diversity within the bronchiectatic lung P Mitchelmore PQDT-UK & Ireland, 2018 | 1 | 2018 |
| Children must be protected from the tobacco industry’s marketing tactics N Hopkinson, C Wallis, B Higgins, S Gaduzo, R Sherrington, S Keilty BMJ 347, 2013 | 1 | 2013 |
| Culture-independent Multilocus Sequence Typing screening for Haemophilus influenzae cross-infection in non-cystic fibrosis bronchiectasis CR Wilson, PJ Mitchelmore, N Withers, AR Brown Diagnostic Microbiology and Infectious Disease, 116327, 2024 | | 2024 |
| Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial P Sandercock, J Darbyshire, D DeMets, R Fowler, D Lalloo, M Munavvar, ... Nature Communications 15, 2024 | | 2024 |
